Current Fungal Infection Reports is an essential academic journal dedicated to the rapidly evolving field of mycology, specifically focusing on the diagnosis, treatment, and epidemiology of fungal infections. Published by Springer, this journal aims to provide a comprehensive platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings and insights into the complexities surrounding fungal diseases. With an ISSN of 1936-3761 and an E-ISSN of 1936-377X, the journal is recognized in the Q3 category for Infectious Diseases as of 2023 and holds a Scopus rank of #199 out of 344 in its field, showcasing its growing influence. Although not currently open access, Current Fungal Infection Reports remains an important resource for those wishing to stay updated on key developments and trends within this critical area of global health. Through its commitment to advancing knowledge and fostering academic exchange, the journal plays a crucial role in combating the challenges posed by fungal infections, making it a must-read for anyone involved in infectious disease research and treatment.

JOURNAL DE MYCOLOGIE MEDICALE is a premier publication in the field of infectious diseases, particularly focusing on the study of mycology and its clinical implications. Published by MASSON EDITEUR, this esteemed journal is based in France and has been disseminating valuable research since its inception in 1994. With an ISSN of 1156-5233 and an E-ISSN of 1773-0449, it plays a critical role in advancing knowledge in mycological infections, positioning itself in the Q3 category for infectious diseases as per the 2023 quartiles. As indicated by its ranking in Scopus, ranking #142 out of 344 in the medicine-infectious diseases category, the journal maintains a prominent presence within the academic community, appealing to researchers, healthcare professionals, and students alike. Although access options are not open access, the journal endeavors to promote a deeper understanding of mycological studies that are crucial for combating ongoing and emerging infectious threats. As it continues to converge on new findings up to 2024, JOURNAL DE MYCOLOGIE MEDICALE remains an essential resource for those invested in the critical intersections of mycology and medicine.

STUDIES IN MYCOLOGY is a premier journal dedicated to advancing research in the field of mycology, published by the renowned WESTERDIJK FUNGAL BIODIVERSITY INSTITUTE. With an impact factor that places it in the top quartile (Q1) of both Agricultural and Biological Sciences and Plant Science categories, it holds a prestigious position in the scientific community, ranking #1 out of 193 in its field as per Scopus metrics. Since its transition to Open Access in 2008, it has made significant strides in disseminating high-quality research widely, fostering a greater understanding of fungal biodiversity and its ecological impact. Covering a broad spectrum of topics related to mycology, the journal aims to provide researchers, professionals, and students with a platform for sharing innovative findings, stimulating academic discourse, and promoting collaborative efforts within this vital area of study. Hailing from the Netherlands, STUDIES IN MYCOLOGY serves as an invaluable resource for exploring the complexities of fungi, their interactions with various ecosystems, and their practical applications in agriculture and beyond.

Fungal Genetics and Biology is a leading peer-reviewed journal published by Academic Press Inc, Elsevier Science, dedicated to advancing the understanding of fungi through innovative genetic and biological research. Since its inception in 1996, this journal has served as a vital platform for the dissemination of critical findings in the fields of Genetics and Microbiology, maintaining a distinguished Q2 category ranking in both disciplines as of 2023. With an ISSN of 1087-1845 and an E-ISSN of 1096-0937, the journal emphasizes the intersection of genetics and molecular biology to explore fundamental questions related to fungal biology that are of paramount importance to various applications in biotechnology, medicine, and environmental science. Researchers, professionals, and students alike will find this journal invaluable as it not only covers current trends and breakthroughs but also encourages collaborative efforts across the scientific community. Fungal Genetics and Biology continues to shape the future of fungal research well into 2024 and beyond, offering rich insights and open access options for a global audience.

MYCOLOGICAL PROGRESS, published by SPRINGER HEIDELBERG, is an esteemed journal dedicated to advancing the field of mycology and associated biological disciplines. With an ISSN of 1617-416X and an E-ISSN of 1861-8952, this journal has established itself as a leading source of high-quality research, evidenced by its impressive rankings in the Q1 quartile across various categories such as Agricultural and Biological Sciences, Ecology, and Plant Science. As of 2023, MYCOLOGICAL PROGRESS ranks 37 out of 193 in Agricultural and Biological Sciences (miscellaneous) and 183 out of 721 in Ecology, demonstrating its significant impact in the ecosystem of scientific literature. This journal not only aims to disseminate innovative research findings but also strives to foster interdisciplinary collaboration among scientists, ecologists, and agriculturists around the globe. While retaining a traditional model of publication, MYCOLOGICAL PROGRESS remains crucial for those seeking to deepen their understanding of fungal biology and its broader environmental implications.

Mycology: An International Journal on Fungal Biology, published by Taylor & Francis Ltd, stands at the forefront of fungal research, facilitating the dissemination of knowledge across the diverse fields of infectious diseases, microbiology, and plant science. Established as an Open Access journal since 2010, it offers researchers free and immediate access to high-quality articles that advance our understanding of fungal biology and its applications. With a commendable ranking in Q2 for Infectious Diseases and Microbiology, and Q1 for Plant Science as of 2023, it positions itself as a vital resource for the global scientific community. The journal, conveniently located in the United Kingdom, is committed to publishing rigorous research that stimulates discussion and fosters collaboration among academics, practitioners, and students alike. By providing a platform for innovative studies and critical reviews, Mycology continues to play an essential role in unraveling the complexities of fungal organisms and their profound implications in health, agriculture, and ecosystem dynamics.

Pathologia is a prominent open-access journal dedicated to advancing the field of clinical and experimental pathology, published by ZAPORIZHZHYA STATE MEDICAL UNIVERSITY. Established in 2013, the journal aims to provide a platform for researchers, clinicians, and students to share innovative research, case studies, and reviews that are critical to understanding disease mechanisms and improving diagnostic and therapeutic strategies. With a steady commitment to high-quality research dissemination and accessibility, this journal serves as an essential resource for those in the medical and health sciences fields. Researchers engaging with Pathologia can explore a diverse range of topics, including histopathology, molecular pathology, and laboratory medicine, promoting both scholarly discussion and practical applications. The journal's open-access model ensures that vital research findings are freely available to the global academic community, fostering a collaborative environment that is crucial for the advancement of pathology as a discipline.

MYCOLOGIA, published by Taylor & Francis Inc, is a prestigious journal that has been at the forefront of fungal research since its inception, with converging years of publication from 1945 to 2024. This interdisciplinary journal, identified by ISSN 0027-5514 and E-ISSN 1557-2536, stands out in various scientific categories, achieving Q1 rankings in Ecology, Evolution, Behavior and Systematics, as well as Plant Science, alongside strong performances in Cell Biology and Molecular Biology categories. With an impact factor that reflects its significance in the field, MYCOLOGIA appeals to a diverse audience, including researchers, professionals, and students dedicated to advancing the understanding of fungal biology and its ecological implications. Notably, while it does not currently operate under an Open Access model, the journal remains a vital resource for those pursuing groundbreaking discoveries in mycology and related disciplines.

Reviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.

Medical Microbiology and Immunology is a renowned journal published by Springer, serving as a pivotal resource in the fields of microbiology and immunology. Established in 1971 and continuing its legacy through 2024, this journal features cutting-edge research and reviews that address critical advancements and challenges within these dynamic fields. With an impressive impact factor and a robust ranking, including Q1 categories in both Microbiology (medical) and Immunology, it stands at the forefront of scholarly communication, ranking 21st out of 140 in the realm of Medical Microbiology. Researchers and professionals are encouraged to explore a variety of studies that delve into the interactions between microorganisms and the immune system, making it an essential resource for anyone fascinated by these interconnected realms of health sciences. Although not open access, the journal is widely accessible through institutional libraries, ensuring that significant findings reach a global audience. The University of New York Plaza serves as its operational hub in the USA, reinforcing its international influence and dedication to advancing knowledge in microbiology and immunology.